A COVID-19 Model

Dare to Bare your Healthcare to the COVID scare

“A COVID-19 Model” by Studio Videnda

“A COVID-19 Model” by Studio Videnda

The COVID-19 pandemic has challenged humanity like nothing before.  From the start, multidisciplinary teams of scientists have worked tirelessly creating and refining mathematical models to foretell the spread and effects of the virus.  These teams include virologists, epidemiologists, infectious disease specialists, other physician specialists, public health experts, information technology experts, and statisticians.  Some of the more prominent modeling groups work at Johns Hopkins University, European Centre for Disease Prevention and Control, the University of Washington Institute for Health Metrics and Evaluation, and the US Centers for Disease Control and Prevention

These models for spread of the coronavirus that causes COVID-19, and incidence of the disease itself, incorporate a large number of input variables and of course generate output variables.  As just one example of how these models work, consider effects of face mask use on COVID-19 mortality rate.  A late June 2020 model from the University of Washington group predicted that 33,000 fewer Americans would die from COVID-19 by October 1 if 95% of Americans wore masks in public to reduce spread of the coronavirus.

 

A lot of work goes into creating and maintaining these models.  Data are almost constantly being updated; variables are added, removed, or manipulated depending on circumstances; models are refined to address different types of questions; and model predictions are back-checked against reality.  If one accepts Kahlil Gibran’s contention that “Work is love made visible,” these models may represent this idea well. 

 

Variables included in the “model” depicted here are listed below.  Some variables listed are not included in every published COVID-19 predictive model, and many other variables are not shown.  Type of model is itself a variable. 

 

Variables Included (in no particular order) 

Serial interval                                                      Incubation period

Reproduction number                                        Mutation rate

Dispersion factor                                                Community spread

Infective dose                                                     Non-human vectors

Asymptomatic carriers                                        Shedding

Nosocomial transmission                                   Confirmed cases

Population demographics                                  Geo-temporal spread

Hand-to-face self-inoculation                            Vulnerable populations

Gain of function                                                   Mobility patterns

Population demographics                                  Post-recovery contagiousness

Surface contamination                                         Attack rate

Fatality rate                                                           Healthcare system capacity

Personal protective equipment                         Patient isolation

Triage                                                                     Essential workers

Healthcare disparities                                           ICU beds

Temperature                                                           Closures

Exponential model                                                 Cluster kinetic model

Doubling period                                                     Superspreading

Incidence                                                                Test sensitivity and specificity

Percent tested                                                        Test result latency

Secondary morbidity / mortality                       Concordance index

Model overfitting                                                   Calibration of predictions

Mask usage                                                             Contact transmission

Aerosols                                                                   Contact tracing

Curfews                                                                    Social distancing

Quarantine Syndromic surveillance

ACE2 (Angiotensin converting enzyme 2)

                                                              

 

MORE REFERENCES 

https://pubmed.ncbi.nlm.nih.gov/32244365/ 

https://pubmed.ncbi.nlm.nih.gov/32265220/ 

https://pubmed.ncbi.nlm.nih.gov/32134116/ 

https://pubmed.ncbi.nlm.nih.gov/32201335/ 

https://pubmed.ncbi.nlm.nih.gov/32179124/ 

https://pubmed.ncbi.nlm.nih.gov/26597631/ 

https://pubmed.ncbi.nlm.nih.gov/24479417/ 

https://pubmed.ncbi.nlm.nih.gov/32035997/ 

https://pubmed.ncbi.nlm.nih.gov/32367431/